Google Custom Search
Podcast Advocacy 2014 HBV Meeting navigation menu

Home

PA Biotech
Liver Cancer Connect
Visit our Baruch Blumberg Institute of Living Science
World Hepatitis Alliance Member
HepB United
About Us
 

Our Accomplishments

The Hepatitis B Foundation has made tremendous strides forward in advancing our Cause for a Cure.

2013

  • HBF renamed its research institute the Baruch S. Blumberg Institute in honor of Co-Founder Dr. Baruch Blumberg, who won the Nobel Prize for his discovery of the hepatitis B virus. For 20 years, Dr. Blumberg was a vital force in the development of the HBF and its research programs until his death in April 2011.
  • HBF launched www.LiverCancerConnect.org, the first patient-focused website that provides information and support to those facing the challenge of primary liver cancer, which is the most serious consequence chronic hepatitis B.
  • The Hep B United national coalition, created and co-chaired by HBF in partnership with AAPCHO, was approved for co-branding with the CDC’s first national “Know Hepatitis B” educational campaign.
  • HBF successfully advocates for the rights of hepatitis B-infected individuals in the United States! Based on our reports to the CDC about many cases of institutional discrimination against hepatitis B–infected healthcare workers and students, the CDC updated its recommendations to clearly state that hepatitis B should not prevent anyone from a healthcare career. These updated recommendations became the cornerstone of a landmark settlement by the U.S. Dept. of Justice on March 5, 2013 that officially recognizes hepatitis B as being protected under the Americans with Disabilities Act (ADA).

2012

  • HBF’s research institute represents the largest concentration of nonprofit scientists in the U.S. working on the problem of hepatitis B and liver cancer.
  • To date, HBF’s research institute scientists are discovering new ways to attack the hepatitis B virus that could lead to promising new targets for drug discovery and an eventual cure.
  • HBF established a new national coalition – Hep B United – in partnership with the Association for Asian and Pacific Community Health Organization (AAPCHO) to promote and leverage the success of community-based coalitions across the country in the fight against hepatitis B and liver cancer.
  • HBF is helping to change clinical practice and national policy with published articles in peer-reviewed journals that highlight the underestimation and undertreatment of hepatitis B in the U.S., and the tremendous need to improve screening for this silent but deadly liver infection.

2011

  • Hepatitis B Foundation Celebrates 20th Anniversary
    Watch the short YouTube video that captures the 20 year history of the Hepatitis B Foundation through old photos and interviews with the founders and Nobel Laureate Dr. Baruch Blumberg. View now!
  • Merck & Co. donated its entire Natural Products Collection to the HBF’s research institute that provides access to a treasure trove for potential new therapies. As many as 50% of all medicines in use today came from natural products.
  • A major American diagnostic company licensed the use to develop HBF’s HCC biomarker in the United States for the early detection of liver cancer; this same biomarker is already being used in China.
  • HBF established its first international public health program in Haimen City, China to conduct a citywide hepatitis B education and outreach effort for the 1 million residents. This was made possible by a 3-year competitive grant from the BMS Foundation.

2010

  • Groundbreaking for nine new labs to accommodate the success of research entrepreneurs and a teaching lab for young scientists occurred in June.
  • HBF was part of the IOM Report on “Hepatitis and Liver Cancer” from inception to fruition by providing testimony and having three of our medical advisors play a major role in this landmark report that set the stage for how the US will manage HBV and liver cancer in the next decade.
  • HBF was at the forefront in working with Congressional members to advocate for HR 3974, the Hepatitis and Liver Cancer Prevention and Control Act 2009, a comprehensive bill that addresses the needs of more than five million Americans living with chronic hepatitis B.

2009

  • The highly competitive GSK IMPACT Award and $40,000 cash prize was awarded to the HBF for its comprehensive Outreach Program that helps improve access to care.
  • John Ellis, a 17-year old cyclist from Florida took his devastating diagnosis of hepatitis B and turned it into an awareness campaign with his Believe in the Cure Cycling Tour of 1,287 miles from Pensacola to Philadelphia and raised $50,000 towards a cure!
  • HBF convened the first National Pediatric Hepatitis B Workshop gathering an expert panel of pediatric liver specialists to discuss the management of children with chronic hepatitis B. Recommendations were published October 5, 2009 in Pediatrics.

2008

  • HBF organized a historic Library of Congress Symposium on HIV and HBV during National Hepatitis B Awareness Week to address the challenges in HIV vaccine development.
  • Dr. Andy Cuconati, head of HBF’s Drug Discovery Program discovered a new compound that specifically suppresses release of HBV from infected liver cells.
  • The Gateway to Care and the Philadelphia Task Force on Hepatitis B was launched to improve access to care through education and free screenings.

2007

2006

2005

  • HBF provides impetus for historic advocacy successes: First-ever National HBV Act introduced in Congress; first Congressional Briefing on HBV; and first National HBV Awareness Week in May called for by Congress.

2004

  • HBF establishes the Institute for Hepatitis and Virus Research, which houses the HBF labs.
  • HBF and University of Oxford Training Program is created - one of the first of its kind in the United States.
  • Drexel University becomes the new academic partner of the HBF.

2003

  • Pennsylvania Governor Mark Schweiker presents a check for $7.9 million to HBF and Delaware Valley College to build a biotechnology research complex.
  • HBF becomes a charter member of the National Viral Hepatitis Roundtable in Washington, D.C.

2002

  • HBF receives a $400,000 National Institutes of Health (NIH) grant to fund a total reconstruction of its website - www.hepb.org.

2001

HBF Co-Founders Still Working Together(2001) The past ten years have only strengthened the commitment of the HBF Founders! L to R: Tim Block, Jan Witte, Paul Witte, and Joan Block.

  • HBF celebrates our 10th Anniversary!

2000

  • The "Bruce Witte Research Fellowship" is established to fund a young scientist pursuing hepatitis B research.
  • College summer research internship program is established
  • 6th annual Princeton Workshop identifies "National Research Priorities for hepatitis B".

1999

  • $1.5 million PA state grant is received to support HBF outreach efforts, promote hepatitis research, and to conduct statewide viral hepatitis trainings.

1998

PA Governor Ridge Proclaims Hepatitis Awareness Month (1997)
HBF President Joan Block (seated on right) and HBF Medical Advisor Dr. Kenneth Rothstein (standing on right) meet Governor Ridge.

  • HBF offices and labs move under one roof to the new Jefferson Center for Biomedical Research, Doylestown, PA

1997

  • HBF outreach campaign results in PA Governor Tom Ridge declaring the first Hepatitis Awareness Month.
  • O'Liver, the HBF liver mascot, makes its debut in a televised press conference on the Capitol in Harrisburg, PA
  • HBF partners with Jefferson Medical College and Delaware Valley College to help establish a new research center in Doylestown, PA

Scientific Leaders Attend First Princeton Workshop (1995)
Sitting L to R: P. Marion, T. Block, J. Hoofnagle, F. Chisari, W. T. London, C. Rogler Standing L to R: D. Averett, D. Standring, C. Seeger, P. Cote, B. Gu, D. Ganem, R. Boehme, J. Summers, H. Isom, W. Mason, W. Gerlich, C. Young, J. O'Connell, R. Lanfod, B. Rennant (missing from photo: N. Brown, L. Johnson, J. Pugh, M. Roggendorf, L. Tyrrell.)

1996

First HBF Gala Honors Distinguished Leaders (1996)
L to R: Prof. Raymond Dwek, Dr. Joseph Gonnella, Mr. Harvey Rich, Dr. Nat Brown, and U.S. Congressman James Greenwood.

Pa. Governor Ridge Proclaims Hepatitis Awareness Month (1997)
HBF President Joan Block (seated on right) and HBF Medical Advisor Dr. Kenneth Rothstein (standing on right) meet Governor Ridge.

Hepatitis B Foundation Lab Opens (1994)
HBF Senior Scientist Dr. Xuanyong Lu (center) demonstrates technique to research associates.

New Hepatitis B Drug Discovered (1993)
Drs. Baruch Blumberg (right) Timothy Block (left) and Raymond Dwek (not pictured) collaborate on hepatitis B research at the University of Oxford.

  • The first official HBF office is opened in Jenkintown, PA
  • HBF goes on-line, creates a website (www.hepb.org) and is flooded with e-mails from around the world.
  • Many new educational materials are developed to respond to the increasing requests for information.
  • HBF advocacy efforts result in PA legislature passing Act 15 that adds the hepatitis B vaccine to the list of immunizations required for school entry.

1995

  • HBF invites 25 of the nation's leading scientists and clinicians to participate in the first Princeton Workshop, which is focused on hepatitis B therapeutic research.
  • HBF reports that lamivudine is a promising new oral drug against hepatitis B.

1994

  • The HBF Research Lab is established at Jefferson Medical College, Philadelphia, PA.

1993

  • A PA state grant is received to produce two Emmy-nominated television Public Service Announcements to promote hepatitis B awareness.
  • Drs. Timothy Block, Baruch Blumberg, and Raymond Dwek discover a new anti-HBV drug< at Oxford University. 

1992

  • A PA state grant received to produce HBF video, "Someone You Know Has Hepatitis B", which includes an introduction by Dr. Nancy Snyderman of Good Morning America.
  • The B Informed Newsletter is launched.

1991

  • HBF incorporates as a 501(c)(3) nonprofit organization.
  • First public HBF fundraiser in New Hope, PA raises $17,000.
  • PA State Senator Jim Greenwood introduces the Hepatitis B Prevention, Research and Treatment Act into legislature.
  • HBF reports that interferon alpha, an injectable drug, shows promise against hepatitis B.


 

Page last modified January 2, 2014

donate
amazon smile

Connect with Us

facebook twitter youtube linkedin
Hep B Blog
Bookmark and Share
Site design by Ferguson Lynch  FL logo